Connection

Walter Ageno to Middle Aged

Back to Details
This is a "connection" page, showing publications Walter Ageno has written about Middle Aged.
Walter Ageno
Connection Strength
0.166
Middle Aged
  1. Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19. Intern Emerg Med. 2021 06; 16(4):989-996.
    View in: PubMed
    Score: 0.015
  2. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency. Thromb Res. 2020 12; 196:209-212.
    View in: PubMed
    Score: 0.014
  3. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry. Thromb Haemost. 2019 Feb; 119(2):319-327.
    View in: PubMed
    Score: 0.013
  4. Breadth of complications of long-term oral anticoagulant care. Hematology Am Soc Hematol Educ Program. 2018 11 30; 2018(1):432-438.
    View in: PubMed
    Score: 0.013
  5. Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study. Br J Haematol. 2018 11; 183(3):457-465.
    View in: PubMed
    Score: 0.012
  6. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study. Vasc Med. 2017 12; 22(6):518-524.
    View in: PubMed
    Score: 0.012
  7. An unusual case of neck pain in Hashimoto's thyroiditis. Intern Emerg Med. 2017 Sep; 12(6):817-819.
    View in: PubMed
    Score: 0.011
  8. Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study. Thromb Res. 2017 Jul; 155:23-27.
    View in: PubMed
    Score: 0.011
  9. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb Haemost. 2017 04 03; 117(4):794-800.
    View in: PubMed
    Score: 0.011
  10. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
    View in: PubMed
    Score: 0.004
  11. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients. J Med Virol. 2021 Sep; 93(9):5648-5649.
    View in: PubMed
    Score: 0.004
  12. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med. 2021 Jun; 16(4):1005-1015.
    View in: PubMed
    Score: 0.004
  13. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.004
  14. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
    View in: PubMed
    Score: 0.004
  15. Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis. Eur J Intern Med. 2019 03; 61:29-33.
    View in: PubMed
    Score: 0.003
  16. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study. Lancet Haematol. 2018 Oct; 5(10):e441-e449.
    View in: PubMed
    Score: 0.003
  17. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. N Engl J Med. 2018 Sep 20; 379(12):1118-1127.
    View in: PubMed
    Score: 0.003
  18. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis. Clin Transl Gastroenterol. 2018 08 15; 9(8):176.
    View in: PubMed
    Score: 0.003
  19. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin. J Clin Pathol. 2018 Nov; 71(11):1015-1022.
    View in: PubMed
    Score: 0.003
  20. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. Thromb Res. 2018 04; 164:69-74.
    View in: PubMed
    Score: 0.003
  21. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study. Thromb Haemost. 2017 12; 117(12):2406-2414.
    View in: PubMed
    Score: 0.003
  22. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.003
  23. Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. Thromb Res. 2017 May; 153:97-100.
    View in: PubMed
    Score: 0.003
  24. Managing challenging patients with venous thromboembolism: a practical, case-based approach. Pol Arch Intern Med. 2017 Jan 04; 127(1):41-46.
    View in: PubMed
    Score: 0.003
  25. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost. 2016 Jan; 115(2):399-405.
    View in: PubMed
    Score: 0.003
  26. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008 Jun 26; 358(26):2776-86.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.